Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site

Dendreon, which last summer changed ownership for a third time in as many years, signaled its faith in prostate drug Provenge by signing a lease extension for its Seal Beach, California, manufacturing facility and headquarters.